These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 963898)

  • 1. Effect of riboflavin treatment on human red cell pyruvate kinase deficiency.
    Blume KG; Arnold H; Hasslinger K; Löhr GW
    Clin Chim Acta; 1976 Sep; 71(2):331-4. PubMed ID: 963898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".
    Beutler E; Forman L; Rios-Larrain E
    Am J Med; 1987 Nov; 83(5):899-904. PubMed ID: 3674096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Magnesium Diasporal on erythrocyte pyruvate kinase activity in healthy persons and in patients with pyruvate kinase deficiency].
    Gumińska M; Wazewska-Czyzewska M
    Folia Med Cracov; 1980; 22(3-4):425-33. PubMed ID: 7286842
    [No Abstract]   [Full Text] [Related]  

  • 4. Normalisation of red blood cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatment.
    Staal GE; van Berkel TJ; Nijessen JG; Koster JF
    Clin Chim Acta; 1975 May; 60(3):323-7. PubMed ID: 1139778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical and laboratory characteristics of congenital pyruvate kinase deficiency].
    Song L; Li Y; Peng GX; Zhang L; Jing LP; Zhou K; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhao YP; Xiong YZ; Wu ZJ; Zhang FK
    Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):511-513. PubMed ID: 29996270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physico-chemical and kinetic properties of pyruvate kinase in erythrocytes in enzymopathic hemolytic anemia].
    Rotrekl B; Wiedermann B; Mlcochová E; Prokopová M
    Vnitr Lek; 1984 Jun; 30(6):542-9. PubMed ID: 6474860
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme deficiencies as the cause of hereditary nonspherocytic hemolytic anemia.
    Casado A; Casado MC; De la Torre MR; López-Fernandez ME; Carrascosa D
    Clin Genet; 1992 Sep; 42(3):160. PubMed ID: 1395088
    [No Abstract]   [Full Text] [Related]  

  • 8. Inherited erythrocyte pyruvate kinase deficiency: Studies on 15 members of two related families.
    Dachà M; Canestrari F; Bossù M; Ferrini PL; Fornaini G
    Acta Haematol; 1977; 57(1):37-46. PubMed ID: 190844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocyte pyruvate kinase in healthy subjects and in nonspherocytic hemolytic pyruvate-kinase deficiency anemia].
    Wiesmann U; Tönz O; Richterich R; Verger P
    Klin Wochenschr; 1965 Dec; 43(24):1311-8. PubMed ID: 5873393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias].
    Maj S; Pawelski S
    Pol Arch Med Wewn; 1968; 40(5):587-9. PubMed ID: 5661498
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyruvate kinase deficiency.
    Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1445-52. PubMed ID: 3328943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Deficiency of pyruvate kinase in erythrocytes: biochemical studies. Preliminary communication].
    Stanulović M; Jerance D; Stojimirović E
    Bilt Hematol Transfuz; 1977; 5(3-4):95-6. PubMed ID: 615616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical studies on mutant red cell enzymes mainly associated with hemolytic anemia.
    Miwa S
    Jinrui Idengaku Zasshi; 1980 Jun; 25(2):83-92. PubMed ID: 7431680
    [No Abstract]   [Full Text] [Related]  

  • 14. [PK deficiency of erythrocytes as cause of hemolytic anemia].
    Larizza P; Brunetti P
    Minerva Pediatr; 1968 Dec; 20(51):2667-81. PubMed ID: 5735249
    [No Abstract]   [Full Text] [Related]  

  • 15. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression.
    Staal GE; Rijksen G; Vlug AM; Vromen-van den Bos B; Akkerman JW; Gorter G; Dierick J; Petermans M
    Clin Chim Acta; 1982 Feb; 118(2-3):241-53. PubMed ID: 7055983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
    Grace RF; Rose C; Layton DM; Galactéros F; Barcellini W; Morton DH; van Beers EJ; Yaish H; Ravindranath Y; Kuo KHM; Sheth S; Kwiatkowski JL; Barbier AJ; Bodie S; Silver B; Hua L; Kung C; Hawkins P; Jouvin MH; Bowden C; Glader B
    N Engl J Med; 2019 Sep; 381(10):933-944. PubMed ID: 31483964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of nonspherocytic hemolytic anemia caused by deficient activity of erythrocyte pyruvate kinase].
    Ermil'chenko GV; Idel'son LI; Shcherbak EM
    Probl Gematol Pereliv Krovi; 1971 Oct; 16(10):58-60. PubMed ID: 5125899
    [No Abstract]   [Full Text] [Related]  

  • 18. Red cell pyruvate kinase deficiency: an optimised assay.
    Lakomek M; Schröter W; Winkler H
    Clin Chim Acta; 1980 Nov; 108(1):31-40. PubMed ID: 7449136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in hereditary red cell enzyme abnormalities.
    Kahn A
    Recent Results Cancer Res; 1979; 69():77-85. PubMed ID: 157513
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitapivat for treatment of pyruvate kinase deficiency.
    Costa FF
    Lancet Haematol; 2022 Oct; 9(10):e708-e709. PubMed ID: 35988547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.